Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Case Comprehensive Cancer Center
University of Washington
University of Louisville
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Fred Hutchinson Cancer Center